https://www.selleckchem.com/pr....oducts/brincidofovir
To assess the impact of interventions for improving the management of chronic obstructive pulmonary disease (COPD), specifically increased use of pulmonary rehabilitation (PR) on patient outcomes and cost-benefit analysis. We used the national Hospital Episode Statistics (HES) datasets in England, local data and experts from the hospital setting, National Prices and National Tariffs, reports and the literature around the effectiveness of PR programs. The COPD pathway was modeled using discrete event simulation (DES) to capture the
Like
Comment
Share
